2025 health care predictions part 3
What top health care leaders expect from the new year
Colin Banas, MD, MHA, Chief Medical Officer, DrFirst
In 2025, we expect to see the continued upward trajectory of specialty medications, especially as GLP-1s gain more evidence for new indications such as heart disease and Alzheimer’s disease. While many healthcare providers and patients enthusiastically embrace these breakthrough drugs, the new uses come with heightened frustration due to complex and time-consuming prior authorization processes. Health IT companies that can prioritize solutions to address these issues quickly and holistically will likely have a substantial advantage over those offering one-off solutions that haven’t quelled providers’ frustrations.
Each new year brings a feeling of endless possibilities and this is felt nowhere more than in the realm of health care which is seeing seismic shifts in technology and policy.
We asked leaders from across the health care space to take out their crystal balls and see if they can give some insight into what awaits the industry in 2025. Here's what they said:
